Last week, Trovita Health Sciences, the company behind ENU Nutritional Shakes, launched a crowdfunding campaign on CircleUp to to continue growth of its flagship brand ENU, and to launch a new patent-pending product for enteral nutrition.
Trovita Health Science is an emerging specialty health and nutrition company, dedicated to developing and commercializing products that address unmet needs in clinical and sports nutrition. Trovita is recognized for innovation in the adult and sports nutrition categories, and was named a Division Winner in the 2014 Minnesota Cup, while ENU was also selected as the 2014 CPG Editor’s Choice Award Winner for the best new innovation in weight management products. ENU is certified by Informed-Choice and has been verified through laboratory testing as being free of all banned substances.
The company shared:
“Our mission of redefining nutrition was borne of a critical need in the marketplace for nutritional products that offer higher quality, natural ingredients, without the use of added sugar, corn syrup and artificial ingredients. Too many nutritional products that are sold today continue to use too little protein and too much sugar to offer any real benefit to the people who need them for clinical uses, such as unwanted weight loss from cancer treatment.
“Trovita develops and commercializes products that offer a unique nutritional profile for both medical use and for use among athletes and general consumers. Our flagship consumer-facing brand is ENU – a non-GMO, high protein / high calorie complete meal replacement shake that is also low in total sugar content, and uses no sucrose or corn syrup. Healthcare professionals have begun to recommend ENU over the traditional products in the category (Boost and Ensure) because it offers higher overall quality and far less sugar.
“Trovita is also launching a new medical food product for enteral nutrition (tube feeding) which will be sold under the brand name Ultrient. This new product has a patented method of administration – which will be life changing for people fed through a tube – and will also provide the same quality of nutrition as ENU.”
Will Brown, CEO at Trovita Health Science added:
“Trovita is pleased to partner with CircleUp to address our working capital requirements as our customer growth and retail stocking for ENU is exceeding our expectations. We are also preparing to launch an exciting new innovation that will both simplify and revolutionize the administration of enteral nutrition for people requiring tube feeding. We are optimistic that CircleUp’s network of accredited investors will appreciate the opportunity that Trovita offers to capture significant market share in a large addressable market, and an opportunity for higher margins.”
Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!
